The successful candidate will work as a Roche Postdoctoral Fellow (RPF) in the Biomarkers and Clinical imaging group, and will be supervised by Dr. Jörg Hipp, the Biomarker and Experimental Medicine Leader responsible for developing EEG / MEG biomarker strategies for early- and late-stage projects at Roche.
The position will initially be granted for 2 years with the possibility for two 1-year extensions. The project will involve different academic collaborations, including the Dept. of Neurophysiology and Pathophysiology headed by Prof. Andreas Engel at the University Medical Center Hamburg-Eppendorf. The goal is to identify, develop and implement disease-related EEG / MEG biomarkers for use in future clinical projects at Roche. In particular, the project will explore the utility of local- and long-range EEG- and MEG-based connectivity measures.
The Biomarkers and Clinical imaging group at Roche is composed of highly skilled and recognized researchers representing a broad range of scientific domains including: EEG, MEG, MRI, PET, neuropsychology, genetics, and molecular biology. The overreaching team goal is to synergistically integrate and combine different biomarkers to provide optimally sensitive measures of disease biology and pharmacodynamics.
Location Switzerland, Basle-Town, Basle
Loading tweets...